| Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7–RILP–p150Glued and late endosome positioning N Rocha, C Kuijl, R Van Der Kant, L Janssen, D Houben, H Janssen, ... Journal of Cell Biology 185 (7), 1209-1225, 2009 | 766 | 2009 |
| Activation of endosomal dynein motors by stepwise assembly of Rab7–RILP–p150Glued, ORP1L, and the receptor βlll spectrin M Johansson, N Rocha, W Zwart, I Jordens, L Janssen, C Kuijl, ... The Journal of cell biology 176 (4), 459-471, 2007 | 580 | 2007 |
| A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility M Kedde, M Van Kouwenhove, W Zwart, JAF Oude Vrielink, R Elkon, ... Nature cell biology 12 (10), 1014-1020, 2010 | 486 | 2010 |
| Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9 G Korkmaz, R Lopes, AP Ugalde, E Nevedomskaya, R Han, K Myacheva, ... Nature biotechnology 34 (2), 192-198, 2016 | 462 | 2016 |
| Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin B Pang, X Qiao, L Janssen, A Velds, T Groothuis, R Kerkhoven, ... Nature communications 4 (1), 1908, 2013 | 458 | 2013 |
| Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis MD Wellenstein, SB Coffelt, DEM Duits, MH van Miltenburg, M Slagter, ... Nature 572 (7770), 538-542, 2019 | 423 | 2019 |
| Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ... Cell reports 3 (2), 342-349, 2013 | 412 | 2013 |
| Genomic and phenotypic heterogeneity in prostate cancer MC Haffner, W Zwart, MP Roudier, LD True, WG Nelson, JI Epstein, ... Nature Reviews Urology 18 (2), 79-92, 2021 | 364 | 2021 |
| The DNA methylation landscape of advanced prostate cancer SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ... Nature genetics 52 (8), 778-789, 2020 | 259 | 2020 |
| TRPM7 is required for breast tumor cell metastasis J Middelbeek, AJ Kuipers, L Henneman, D Visser, I Eidhof, ... Cancer research 72 (16), 4250-4261, 2012 | 256 | 2012 |
| Prostate cancer reactivates developmental epigenomic programs during metastatic progression MM Pomerantz, X Qiu, Y Zhu, DY Takeda, W Pan, SC Baca, A Gusev, ... Nature genetics 52 (8), 790-799, 2020 | 207 | 2020 |
| Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis CJ Desmet, T Gallenne, A Prieur, F Reyal, NL Visser, BS Wittner, MA Smit, ... Proceedings of the National Academy of Sciences 110 (13), 5139-5144, 2013 | 200 | 2013 |
| IL6/STAT3 signaling hijacks estrogen receptor α enhancers to drive breast cancer metastasis R Siersbæk, V Scabia, S Nagarajan, I Chernukhin, EK Papachristou, ... Cancer cell 38 (3), 412-423. e9, 2020 | 191 | 2020 |
| The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact LF van Dessel, J van Riet, M Smits, Y Zhu, P Hamberg, ... Nature communications 10 (1), 5251, 2019 | 182 | 2019 |
| The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer TE Hickey, LA Selth, KM Chia, G Laven-Law, HH Milioli, D Roden, ... Nature medicine 27 (2), 310-320, 2021 | 180 | 2021 |
| A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response O Krijgsman, P Roepman, W Zwart, JS Carroll, S Tian, FA de Snoo, ... Breast cancer research and treatment 133, 37-47, 2012 | 178 | 2012 |
| Phosphatidylinositol 4-kinaseβ is critical for functional association of rab11 with the Golgi complex P de Graaf, WT Zwart, RAJ van Dijken, M Deneka, TKF Schulz, N Geijsen, ... Molecular biology of the cell 15 (4), 2038-2047, 2004 | 157 | 2004 |
| Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape W Zwart, A Griekspoor, C Kuijl, M Marsman, J van Rheenen, H Janssen, ... Immunity 22 (2), 221-233, 2005 | 152 | 2005 |
| Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance LA Martin, R Ribas, N Simigdala, E Schuster, S Pancholi, T Tenev, ... Nature communications 8 (1), 1865, 2017 | 150 | 2017 |
| Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface IJ De Vries-van Leeuwen, D da Costa Pereira, KD Flach, SR Piersma, ... Proceedings of the National Academy of Sciences 110 (22), 8894-8899, 2013 | 146 | 2013 |
